Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intervention pilot trial for suppression of colibactin-producing E. coli implicated in colorectal carcinogenesis
jRCTs051190073Completed
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Dec 2019
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of Biolactis in colon neoplasm and colorectal cancer (CRC), sponsored by Japan Agency for Medical Research and Development. Started Dec 2019; status: completed.
02
Drugs
Biolactis
03
Conditions
colon neoplasmcolorectal cancer (CRC)
Beyond the preview
Go deeper on jRCTs051190073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051190073.